These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 28939626)

  • 1. Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).
    Ugarte-Gil MF; Wojdyla D; Pons-Estel GJ; Catoggio LJ; Drenkard C; Sarano J; Berbotto GA; Borba EF; Sato EI; Tavares Brenol JC; Uribe O; Ramirez Gómez LA; Guibert-Toledano M; Massardo L; Cardiel MH; Silveira LH; Chacón-Diaz R; Alarcón GS; Pons-Estel BA;
    Ann Rheum Dis; 2017 Dec; 76(12):2071-2074. PubMed ID: 28939626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.
    Ugarte-Gil MF; Wojdyla D; Pons-Estel GJ; Quintana R; Gómez-Puerta JA; Catoggio LJ; Alvarellos A; Saurit V; Borba E; Sato E; Costallat L; Da Silva NA; Iglesias-Gamarra A; Neira O; Reyes-Llerena G; Cardiel MH; Amigo MC; Acevedo-Vásquez E; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA
    J Rheumatol; 2019 Oct; 46(10):1299-1308. PubMed ID: 30824636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
    Ugarte-Gil MF; Hanly J; Urowitz M; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Clarke AE; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Lim S; Inanc M; Kalunian K; Jacobsen S; Peschken C; Kamen DL; Askanase A; Pons-Estel BA; Alarcón GS
    Ann Rheum Dis; 2022 Nov; 81(11):1541-1548. PubMed ID: 35944946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission.
    Zen M; Iaccarino L; Gatto M; Saccon F; Larosa M; Ghirardello A; Punzi L; Doria A
    Ann Rheum Dis; 2018 Jan; 77(1):104-110. PubMed ID: 28970217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort.
    Alarcón GS; Ugarte-Gil MF; Pons-Estel G; Vilá LM; Reveille JD; McGwin G
    Lupus; 2019 Mar; 28(3):423-426. PubMed ID: 30678605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL).
    Reátegui-Sokolova C; Ugarte-Gil MF; Harvey GB; Wojdyla D; Pons-Estel GJ; Quintana R; Serrano-Morales RM; Sacnun MP; Catoggio LJ; Soriano ER; García MA; Saurit V; Alvarellos A; Caeiro F; Berbotto GA; Sato EI; Borba Neto EF; Bonfa E; de Oliveira E Silva Montandon AC; Da Silva NA; Cavalcanti F; Vásquez G; Guibert-Toledano M; Reyes-Llerena GA; Massardo L; Neira OJ; Cardiel MH; Barile-Fabris LA; Amigo MC; Silveira LH; Portela-Hernández M; Garcia de la Torre I; Segami MI; Chacón-Diaz R; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA;
    RMD Open; 2020 Dec; 6(3):. PubMed ID: 33310863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Better Health-Related Quality of Life in Systemic Lupus Erythematosus Predicted by Low Disease Activity State/Remission: Data From the Peruvian Almenara Lupus Cohort.
    Ugarte-Gil MF; Gamboa-Cárdenas RV; Reátegui-Sokolova C; Medina-Chinchón M; Zevallos F; Elera-Fitzcarrald C; Pimentel-Quiroz V; Cucho-Venegas JM; Rodríguez-Bellido Z; Pastor-Asurza CA; Alarcón GS; Perich-Campos R
    Arthritis Care Res (Hoboken); 2020 Aug; 72(8):1159-1162. PubMed ID: 31199590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients.
    Reátegui-Sokolova C; Rodríguez-Bellido Z; Gamboa-Cárdenas RV; Medina M; Zevallos F; Pimentel-Quiroz VR; Elera-Fitzcarrald C; Cucho-Venegas M; Pastor-Asurza CA; Perich-Campos R; Alarcón GS; Ugarte-Gil MF
    Lupus; 2019 Oct; 28(11):1344-1349. PubMed ID: 31551028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage.
    Brunner HI; Jones OY; Lovell DJ; Johnson AM; Alexander P; Klein-Gitelman MS
    Lupus; 2003; 12(8):600-6. PubMed ID: 12945718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of systemic lupus erythematosus (SLE) Disease Activity Score and SLE Disease Activity Index 2000-based remission states in patients with SLE on damage accrual.
    Chitpet P; Chaiamnuay S; Narongroeknawin P; Asavatanabodee P; Leosuthamas P; Pakchotanon R
    Int J Rheum Dis; 2023 Dec; 26(12):2509-2516. PubMed ID: 37875327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
    Barber MRW; Ugarte-Gil MF; Hanly JG; Urowitz MB; St-Pierre Y; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Lim SS; Inanc M; Kalunian KC; Jacobsen S; Peschken CA; Kamen DL; Askanase A; Pons-Estel BA; Cardwell FS; Alarcón GS; Clarke AE
    Ann Rheum Dis; 2024 Sep; 83(10):1295-1303. PubMed ID: 38754981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
    Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
    Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of disease flares in a Chinese lupus cohort with low-grade disease activity.
    Sun F; Zhao L; Wang H; Zhang D; Chen J; Wang X; Li T; Ye S
    Lupus Sci Med; 2022 May; 9(1):. PubMed ID: 35606018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients.
    Reátegui-Sokolova C; Ugarte-Gil MF; Gamboa-Cárdenas RV; Zevallos F; Cucho-Venegas JM; Alfaro-Lozano JL; Medina M; Rodriguez-Bellido Z; Pastor-Asurza CA; Alarcón GS; Perich-Campos RA
    Clin Rheumatol; 2017 Apr; 36(4):845-852. PubMed ID: 28101832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease features and outcomes in United States lupus patients of Hispanic origin and their Mestizo counterparts in Latin America: a commentary.
    Ugarte-Gil MF; Pons-Estel GJ; Molineros J; Wojdyla D; McGwin G; Nath SK; Pons-Estel BA; Alarcón-Riquelme M; Alarcón GS
    Rheumatology (Oxford); 2016 Mar; 55(3):436-40. PubMed ID: 26412809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.
    Ugarte-Gil MF; Wojdyla D; Pastor-Asurza CA; Gamboa-Cárdenas RV; Acevedo-Vásquez EM; Catoggio LJ; García MA; Bonfá E; Sato EI; Massardo L; Pascual-Ramos V; Barile LA; Reyes-Llerena G; Iglesias-Gamarra A; Molina-Restrepo JF; Chacón-Díaz R; Alarcón GS; Pons-Estel BA
    Lupus; 2018 Apr; 27(4):536-544. PubMed ID: 28857715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.
    Pimentel-Quiroz VR; Ugarte-Gil MF; Harvey GB; Wojdyla D; Pons-Estel GJ; Quintana R; Esposto A; García MA; Catoggio LJ; Cardiel MH; Barile LA; Amigo MC; Sato EI; Bonfa E; Borba E; Lavras Costallat LT; Neira OJ; Massardo L; Guibert-Toledano M; Chacón-Díaz R; Alarcón GS; Pons-Estel BA
    Lupus; 2019 Aug; 28(9):1101-1110. PubMed ID: 31291843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age at diagnosis and health-related quality of life are associated with fatigue in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort.
    Elera-Fitzcarrald C; Reátegui-Sokolova C; Gamboa-Cárdenas RV; Medina M; Zevallos F; Pimentel-Quiroz VR; Zeña-Huancas PA; Pastor-Asurza CA; Perich-Campos RA; Rodríguez-Bellido ZJ; Alarcón GS; Ugarte-Gil MF
    Lupus; 2020 Oct; 29(12):1644-1649. PubMed ID: 32741305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort.
    Nieto R; Quintana R; Zavala-Flores E; Serrano R; Roberts K; Catoggio LJ; García MA; Berbotto GA; Saurit V; Bonfa E; Borba EF; Lavras Costallat LT; Da Silva NA; Sato EI; Tavares Brenol JC; Massardo L; Neira OJ; Vázquez G; Guibert Toledano M; Pascual-Ramos V; Sauza Del Pozo MJ; Barile-Fabris LA; Amigo MC; García De La Torre I; Acevedo-Vásquez EM; Segami MI; Chacón-Díaz R; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA; Pons-Estel GJ
    Lupus; 2024 Apr; 33(4):340-346. PubMed ID: 38334100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
    Bruce IN; O'Keeffe AG; Farewell V; Hanly JG; Manzi S; Su L; Gladman DD; Bae SC; Sanchez-Guerrero J; Romero-Diaz J; Gordon C; Wallace DJ; Clarke AE; Bernatsky S; Ginzler EM; Isenberg DA; Rahman A; Merrill JT; Alarcón GS; Fessler BJ; Fortin PR; Petri M; Steinsson K; Dooley MA; Khamashta MA; Ramsey-Goldman R; Zoma AA; Sturfelt GK; Nived O; Aranow C; Mackay M; Ramos-Casals M; van Vollenhoven RF; Kalunian KC; Ruiz-Irastorza G; Lim S; Kamen DL; Peschken CA; Inanc M; Urowitz MB
    Ann Rheum Dis; 2015 Sep; 74(9):1706-13. PubMed ID: 24834926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.